Tatva Chintan Pharma Chem Limited

NSEI:TATVA Voorraadrapport

Marktkapitalisatie: ₹19.3b

Tatva Chintan Pharma Chem Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Tatva Chintan Pharma Chem heeft een totaal eigen vermogen van ₹7.4B en een totale schuld van ₹152.3M, wat de schuld-eigenvermogensverhouding op 2.1% brengt. De totale activa en totale passiva bedragen respectievelijk ₹8.1B en ₹694.2M. De EBIT Tatva Chintan Pharma Chem is ₹197.1M waardoor de rentedekking -11.6 is. Het heeft contanten en kortetermijnbeleggingen van ₹148.7M.

Belangrijke informatie

2.1%

Verhouding schuld/eigen vermogen

₹152.31m

Schuld

Rente dekkingsratio-11.6x
Contant₹148.73m
Aandelen₹7.38b
Totaal verplichtingen₹694.18m
Totaal activa₹8.07b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Sep 26
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Price In Tune With Revenues

Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Aug 29
Tatva Chintan Pharma Chem (NSE:TATVA) Has Affirmed Its Dividend Of ₹2.00

Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Jul 27
Earnings Report: Tatva Chintan Pharma Chem Limited Missed Revenue Estimates By 33%

Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

May 11
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)

Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

Apr 04
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion

These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Jan 26
These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts

Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

May 10
Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year

Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Jul 28
Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next

Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Jun 17
Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely

Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

May 03
Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings

Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Dec 06
Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( ₹2.5B ) TATVA } overtreffen de korte termijn passiva ( ₹678.2M ).

Langlopende schulden: De kortetermijnactiva TATVA ( ₹2.5B ) overtreffen de langetermijnschulden ( ₹15.9M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 0.05% ) TATVA wordt als voldoende beschouwd.

Schuld verminderen: De schuld/eigen vermogen-ratio van TATVA is de afgelopen 5 jaar gedaald van 85% naar 2.1%.

Schuldendekking: De schuld van TATVA wordt goed gedekt door de operationele kasstroom ( 259.2% ).

Rentedekking: TATVA verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.


Balans


Ontdek gezonde bedrijven